Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medikit CoTSE:7749 -0.17%85 EV-to-EBITDA is 3.16 as of Aug. 30, 2026, which is 36% below its 10-year median of 4.91. GuruFocus rates TSE:7749 with a GF Score™ of 85/100 and a GF Value™ of 円3,232.99 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 520 Medical Devices & Instruments companies, Medikit Co ranks better than 94.23% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medikit Co's enterprise value is 円21,359 Mil.
Medikit Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円6,765 Mil. Therefore, Medikit Co's EV-to-EBITDA for today is 3.16.
The historical rank and industry rank for Medikit Co's EV-to-EBITDA or its related term are showing as below:
TSE:7749'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.87 Med: 4.91 Max: 9.66
Current: 3.16
During the past 13 years, the highest EV-to-EBITDA of Medikit Co was 9.66. The lowest was 1.87. And the median was 4.91.
TSE:7749's EV-to-EBITDA is ranked better than 94.23% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.66
vs TSE:7749: 3.16
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medikit Co's share price for today is 円2855.00.
Medikit Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円215.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medikit Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7749 vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Medikit Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medikit Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medikit Co's EV-to-EBITDA falls into.
Medikit Co's current Enterprise Value is 円21,359 Mil.
Medikit Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,765 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medikit Co (TSE:7749) has a EV-to-EBITDA of 3.16 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medikit Co. This is 36% below median its historical median of 4.91. Over the past decade, Medikit Co's EV-to-EBITDA has ranged from 1.87 to 9.66. According to the industry distribution chart, Medikit Co ranks #30 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 5.8%.
Is Medikit Co's EV-to-EBITDA too high?
Medikit Co's current EV-to-EBITDA of 3.16 is 36% below median its 10-year median of 4.91. Over the past 10 years, this metric has ranged from a low of 1.87 to a high of 9.66. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.66. Medikit Co's value of 3.16 is 78.4% below this industry median. Based on the distribution chart, Medikit Co ranks #30 out of 520 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medikit Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #30 out of 520 companies for EV-to-EBITDA. This places Medikit Co in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.66. Medikit Co's value of 3.16 is 78.4% below this benchmark. Historically, Medikit Co's own EV-to-EBITDA has ranged from 1.87 to 9.66 over the past decade. While the company's 10-year median is 4.91 vs. the industry median of 14.66, Medikit Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.66, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medikit Co's current EV-to-EBITDA of 3.16 is 78.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medikit Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current EV-to-EBITDA is 3.16, which is 36% below median its own 10-year median of 4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,232.99, compared to a current price of 円2,855.00 — trading 11.7% below its estimated fair value. The current EV-to-EBITDA is 3.16, which is 36% below median its 10-year median of 4.91 and 78.4% below the Medical Devices & Instruments industry median of 14.66. Medikit Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current EV-to-EBITDA is 3.16 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medikit Co (TSE:7749) Overvalued in 2026?
Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued.
The current stock price of 円2,855.00 is trading 11.7% below its estimated GF Value™ of 円3,232.99.
GuruFocus considers Medikit Co to be Modestly Undervalued.
Key valuation signals for TSE:7749:
EV-to-EBITDA: 3.16 (36% below median its 10-year median of 4.91)
GF Value™: 円3,232.99 vs. price of 円2,855.00 (11.7% below fair value)
Industry Position: 78.4% below the Medical Devices & Instruments median (#30 of 520)
No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
85GF Score
Get the complete analysis for TSE:7749
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7749 has been successfully added to your 
